elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35606384-42DA8F8E-63B7-47B9-9745-08977C3482E0
Q35606384-42DA8F8E-63B7-47B9-9745-08977C3482E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35606384-42DA8F8E-63B7-47B9-9745-08977C3482E0
HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.
P2860
Q35606384-42DA8F8E-63B7-47B9-9745-08977C3482E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35606384-42DA8F8E-63B7-47B9-9745-08977C3482E0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69064032bd20bb3fe868feb95fc8a7dd55fa783a
P2860
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.